Business, energy, technology, markets and global industry news from Business News Today

neoadjuvant therapy

PharmaDeviceNews neoadjuvant therapy
Medical Devices & Diagnostics

Can ultrasensitive ctDNA monitoring reshape how clinicians track neoadjuvant breast cancer therapy response?

New PREDICT-DNA data suggests ultrasensitive ctDNA monitoring may outperform traditional markers in breast cancer relapse prediction. Read the full analysis.

Read More
Medical Devices & Diagnostics

Can personalized ctDNA finally solve the risk stratification gap in therapy-resistant early breast cancer?

New I-SPY 2 data suggest personalized ctDNA could transform risk stratification in therapy-resistant early breast cancer. Read the full analysis.

Read More